Chase Medical Research

Waterbury, Connecticut 06708-3346

1 studies enrolling now · 9 studies all time

What they study most

COVID-19, Diabetes, Diabetes Mellitus, Type 2, Diabetic Peripheral Neuropathic Pain, Migraine, Migraine With Aura, Migraine Without Aura, Obesity or Overweight, Pneumococcal Vaccines, SARS-CoV2, Type 2 Diabetes Mellitus

Studies at this site

• Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy — Recruiting now
• A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity — Completed
• A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes — Running, not enrolling
• Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination — Running, not enrolling
• A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection — Running, not enrolling
• Eversense® Non-adjunctive Use Post Approval Study — Running, not enrolling
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus — Completed
• Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes — Completed